Synopsis
Guidance on bringing software as a medical device to market This guidance provides an overview of the regulatory steps to consider when bringing software as a medical device (SaMD) to market in Great Britain and/or Northern Ireland.
Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.
Read the full story at MHRA (UK medicines regulator) ↗